HEPATOCELLULAR CARCINOMA

This adverse event was reported 7612 times

These drugs are most commonly taken by patients reporting HEPATOCELLULAR CARCINOMA:

# Drug Count
0 SORAFENIB 1899
1 RIBAVIRIN 967
2 SOFOSBUVIR 911
3 BEVACIZUMAB 809
4 REGORAFENIB 488
5 LEDIPASVIR AND SOFOSBUVIR 402
6 TACROLIMUS 307
7 CABOZANTINIB 264
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 255
9 TACROLIMUS OINTMENT 0.1% 255
See all common drugs associated with HEPATOCELLULAR CARCINOMA

HEPATOCELLULAR CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SORAFENIB 1899 0.0917
1 NITISINONE 61 0.0638
2 SOFOSBUVIR 911 0.0464
3 REGORAFENIB 488 0.0420
4 ADEFOVIR DIPIVOXIL 34 0.0268
5 LEDIPASVIR AND SOFOSBUVIR 402 0.0210
6 ENTECAVIR 216 0.0183
7 RIBAVIRIN 967 0.0151
8 VELPATASVIR AND SOFOSBUVIR 118 0.0092
9 TENOFOVIR DISOPROXIL FUMARATE TABLETS 69 0.0080
See all drugs enriched for association with HEPATOCELLULAR CARCINOMA